๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Fas ligand expression, clinicopathologicai features and outcome in human colorectal cancer


Book ID
105723394
Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
204 KB
Volume
170
Category
Article
ISSN
1863-4362

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Expression of Fas ligand is an early eve
โœ Masaaki Shimoyama; Tatsuo Kanda; Lili Liu; Yu Koyama; Takeyasu Suda; Yasuo Sakai ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 364 KB ๐Ÿ‘ 1 views

## Background and objectives: Fas ligand (fasl) is expressed in many cancers and plays an important role in establishing immunologically privileged environments that allow tumors to escape the host's immune surveillance. we investigate the expression of fasl in human colorectal cancer and colorecta

Fas and Fas ligand: strong co-expression
โœ Roskams, Tania; Libbrecht, Louis; Van Damme, Boudewijn; Desmet, Valeer ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 245 KB ๐Ÿ‘ 1 views

Fas (Apo-1, CD95), a member of the nerve growth factor/tumour necrosis factor receptor superfamily, mediates apoptosis in response to agonistic antibodies or Fas ligand (Fas-L) binding. Fas has been shown to be present on hepatocyte membranes in normal liver and in chronic hepatitis C. At the presen